✦ LIBER ✦

Assessing the quality of life of postmenopausal women randomized into the ATAC (“arimidex”, tamoxifen, alone or in combination) adjuvant breast cancer trial

✍ Scribed by L. Fallowfield; D. Cella

Book ID: 114315660
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 223 KB
Volume: 12
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(03)80136-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3–38 Quality of Life of Postmenopausal W

3–38 Quality of Life of Postmenopausal Women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial

✍ Vassilopoulou-Sellin, R. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Quality of Life of Postmenopausal Women

Quality of Life of Postmenopausal Women in the ATAC (“Arimidex”, Tamoxifen, Alone or in Combination) Trial after Completion of 5

✍ David Cella; Lesley Fallowfield; Peter Barker; Jack Cuzick; Gershon Locker; Anth 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 205 KB

The ATAC (Arimidex™, Tamoxifen, Alone or

The ATAC (Arimidex™, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal patients: factors influencing the success of patient recruitment

✍ Mike Baum 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 69 KB

The ATAC (Arimidex™, Tamoxifen, Alone or

The ATAC (Arimidex™, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal (PM) patients (pts): Factors influencing the success of PT recruitment

✍ M. Baum 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Anastrozole alone or in combination with

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer : Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses

✍ The ATAC (Arimidex; Tamoxifen Alone or in Combination) Trialists' Group 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract ## BACKGROUND The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow‐up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer, anastrozole was superior to tamoxifen in terms of d

Results of the ATAC (Arimidex, Tamoxifen

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 66 KB